Last edition
News about "Merck KGaA Deal with Valo Health"
Merck KGaA Inks Up to USD 3 Billion AI-Driven Drug Discovery Deal with Valo Health
Merck KGaA has entered into a major strategic collaboration with Valo Health to use Valo’s AI-powered human causal biology platform for discovering and developing new treatments for Parkinson’s disease and related disorders.
Merck KGaA Deal With Valo Health | 21/11/2025 | By Darshana | 405
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members